Perceptive Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,667,123
| Closed | -$16M | – | 98 |
|
|
2022
Q3 | $16M | Sell |
1,667,123
-1,978,348
| -54% | -$19M | 0.47% | 52 |
|
|
2022
Q2 | $26.4M | Sell |
3,645,471
-1,050,377
| -22% | -$7.6M | 0.83% | 28 |
|
|
2022
Q1 | $60.6M | Sell |
4,695,848
-711,950
| -13% | -$9.19M | 1.21% | 22 |
|
|
2021
Q4 | $86.3M | Buy |
5,407,798
+628,411
| +13% | +$10M | 1.33% | 20 |
|
|
2021
Q3 | $76.8M | Buy |
4,779,387
+81,775
| +2% | +$1.31M | 1.12% | 25 |
|
|
2021
Q2 | $65M | Hold |
4,697,612
| – | – | 0.84% | 33 |
|
|
2021
Q1 | $68.6M | Buy |
4,697,612
+25,776
| +0.6% | +$377K | 0.87% | 28 |
|
|
2020
Q4 | $81.2M | Buy |
4,671,836
+1,035,351
| +28% | +$18M | 0.87% | 34 |
|
|
2020
Q3 | $66.7M | Buy |
3,636,485
+3,091,200
| +567% | +$56.7M | 0.97% | 25 |
|
|
2020
Q2 | $9.74M | Buy |
+545,285
| New | +$9.74M | 0.16% | 82 |
|
|
2015
Q3 | – | Sell |
-258,716
| Closed | -$7.48M | – | 145 |
|
|
2015
Q2 | $7.48M | Buy |
258,716
+173,428
| +203% | +$5.01M | 0.45% | 45 |
|
|
2015
Q1 | $2.61M | Sell |
85,288
-352,712
| -81% | -$10.8M | 0.2% | 72 |
|
|
2014
Q4 | $7.15M | Buy |
+438,000
| New | +$7.15M | 0.6% | 39 |
|